• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSIGHTEC LTD. EXABLATE 4000; MR GUIDED FOCUSED ULTRASOUND SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSIGHTEC LTD. EXABLATE 4000; MR GUIDED FOCUSED ULTRASOUND SYSTEM Back to Search Results
Model Number 4000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Muscle Weakness (1967); Dysphasia (2195)
Event Date 03/08/2024
Event Type  Injury  
Manufacturer Narrative
The retrospective analysis has not indicated any technical failures of the system.Treatment parameters were in line with the typical range.The system performance was found to be according to spec and as expected.No new risk has been recognized.No misalignment or smearing were seen on thermal images during the treatment and no heating outside the targeted area.Lesion is in the vim in the thalamus, as expected.Location of the middle cerebral artery (mca) stroke caused damage in the left temporal lobe, which is outside the targeted area and explains the symptoms that are known for stroke in this location.Cardiac evaluation post stroke demonstrated aortic stenosis and new onset atrial flutter, both significant stroke risk factors.According to the information for prescribers (pub41002923 ver.11) the following contraindications are listed: "patients with unstable cardiac status or severe hypertension".
 
Event Description
Patient was treated using focused ultrasound for essential tremor on the left side to treat the right hand tremor on (b)(6) 2024.The patient was discharged 3 hours after treatment with no neurolgoical deficits and was prescribed decadron.The next morning, we was found on the side of his bed and had right sided weakness and unable to speak.Emergency services transferred him to the hospital where he received fus treatment on (b)(6) 2024 the patient was diagnosed with dysphasia, mild legarthy, global aphasia, and was confirmed to have suffered a left mca stroke.Cardiac evaluation post stroke demonstrated aortic stenosis and new onset atrial flutter, both significant stroke risk factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXABLATE 4000
Type of Device
MR GUIDED FOCUSED ULTRASOUND SYSTEM
Manufacturer (Section D)
INSIGHTEC LTD.
5 nachum heth
tirat carmel, 39120
IS  39120
Manufacturer (Section G)
INSIGHTEC LTD.
5 nachum heth
tirat carmel, 39120
IS   39120
Manufacturer Contact
may zimmerman
5 nachum heth
tirat carmel, 39120
IS   39120
MDR Report Key19056928
MDR Text Key339552610
Report Number9615058-2024-00012
Device Sequence Number1
Product Code POH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number4000
Device Catalogue NumberSYS943503
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/08/2024
Initial Date FDA Received04/07/2024
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
-
-